سعر ريباجليد 2مجم 10 قرص 2022

Repaglid

معلومات الدواء

عن الدواءAbout the medicine

Repaglinide 2 mg tablets, pack of 10; short-acting insulin secretagogue for type 2 diabetes.

دواعي الاستعمالUses

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.الفئة: AdultsDailyMed (U.S. National Library of Medicine)

Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.Population: AdultsDailyMed (U.S. National Library of Medicine)

الآثار الجانبيةSide effects

Hypoglycemia, upper respiratory infection, headache, sinusitis, arthralgia, nausea, diarrhea and back pain.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

Hypoglycemia, upper respiratory infection, headache, sinusitis, arthralgia, nausea, diarrhea and back pain.International label, same formulation · DailyMed (U.S. National Library of Medicine)

موانع الاستعمالContraindications

Concomitant use with gemfibrozil.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
Known hypersensitivity to repaglinide or inactive ingredients.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

Concomitant use with gemfibrozil.International label, same formulation · DailyMed (U.S. National Library of Medicine)
Known hypersensitivity to repaglinide or inactive ingredients.International label, same formulation · DailyMed (U.S. National Library of Medicine)

تحذيرات واحتياطاتWarnings & precautions

Hypoglycemia, which may be severe; risk increased with renal/hepatic impairment, missed meals, alcohol or other glucose-lowering drugs.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
Not recommended in combination with NPH insulin.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
No clinical studies establish macrovascular risk reduction.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

Hypoglycemia, which may be severe; risk increased with renal/hepatic impairment, missed meals, alcohol or other glucose-lowering drugs.International label, same formulation · DailyMed (U.S. National Library of Medicine)
Not recommended in combination with NPH insulin.International label, same formulation · DailyMed (U.S. National Library of Medicine)
No clinical studies establish macrovascular risk reduction.International label, same formulation · DailyMed (U.S. National Library of Medicine)

التداخلات الدوائيةDrug interactions

GemfibrozilContraindicated: markedly increased repaglinide exposure.DailyMed (U.S. National Library of Medicine)
ClopidogrelIncreased exposure; avoid, or limit total daily repaglinide to 4 mg.DailyMed (U.S. National Library of Medicine)
CyclosporineIncreased exposure; limit daily repaglinide to 6 mg.DailyMed (U.S. National Library of Medicine)

GemfibrozilContraindicated: markedly increased repaglinide exposure.DailyMed (U.S. National Library of Medicine)
ClopidogrelIncreased exposure; avoid, or limit total daily repaglinide to 4 mg.DailyMed (U.S. National Library of Medicine)
CyclosporineIncreased exposure; limit daily repaglinide to 6 mg.DailyMed (U.S. National Library of Medicine)

الحمل والرضاعةPregnancy & breastfeeding

Limited data have not identified a drug-associated risk of major birth defects or miscarriage; poorly controlled diabetes carries maternal and fetal risks.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)
Breastfeeding is not recommended during treatment because of potential neonatal hypoglycemia.نشرة دولية لنفس التركيبة · DailyMed (U.S. National Library of Medicine)

Limited data have not identified a drug-associated risk of major birth defects or miscarriage; poorly controlled diabetes carries maternal and fetal risks.International label, same formulation · DailyMed (U.S. National Library of Medicine)
Breastfeeding is not recommended during treatment because of potential neonatal hypoglycemia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

كيف يعمل الدواءHow it works

Closes ATP-dependent potassium channels in pancreatic beta cells, stimulating glucose-dependent insulin release.

Repaglinide: Closes ATP-dependent potassium channels in pancreatic beta cells, stimulating glucose-dependent insulin release.

نفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.

مثائل ريباجليد 2مجم 10 قرص بنفس المادة الفعالة والتركيز، مرتبة من الأرخص
الدواء	السعر	الفرق عن الأصلي
روزموند 2مجم 10 اقراصRosemond 2 mg tabletsCopad Pharma · أقراص · 2 mgالأرخص	السعر8.5ج.م0.85ج.م للوحدة	الفرق عن الأصليأغلى 2ج.م (30.8%)
رييباندين 2مجم 10 اقراصRepandin 2mg 10 tabPharopharma · 2 mg	السعر12ج.م1.2ج.م للوحدة	الفرق عن الأصليأغلى 5.5ج.م (84.6%)
مورجابيلون 2مجم 30 اقراصMorgabilon 2 mg 30 tabsGlobal Pharmaceutical Industries · أقراص · 2 mg	السعر24ج.م0.8ج.م للوحدة	الفرق عن الأصليأغلى 17.5ج.م (269.2%)
جلوكونورم 2 مجم 30 قرصGluconorm 2 mg 30 tab.MUP · قرص · 2 mg	السعر28.8ج.م0.96ج.م للوحدة	الفرق عن الأصليأغلى 22.3ج.م (343.1%)
ريباجلينيد 2مجم 30 اقراصRepaglinide 2 mg 30 tabEipico · 2 mg	السعر63ج.م2.1ج.م للوحدة	الفرق عن الأصليأغلى 56.5ج.م (869.2%)

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.